Clinical Trial Evaluating the Efficacy and Safety of Technosphere® Inhalation Insulin (TI) Inhalation Powder Using the Gen2 Inhaler

NCT01196104 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

39

Enrollment

INDUSTRY

Sponsor class

Stopped For Business Reasons

Conditions

Type 2 Diabetes

Interventions

DRUG: Technosphere® Insulin Inhalation Powder
DRUG: Insulin Aspart
DRUG: Insulin Glargine

Sponsor

Mannkind Corporation